In addition to anti-SSA/Ro antibodies, this study investigated the presence of other immunological factors, such as anti-SSB/La antibodies, ANA, and RF, which are not currently included in the classification criteria of SS. This evidence concerns the gene TRIM21 and synovial sarcoma.